How Much Can the Brain Change
Victor asked: we have coping mechanisms, elastic brains, anticipated pleasure — to what degree can we actually change the biochemistry of our brain?
The culture says: you can’t cure autism, ADHD, bipolar, schizophrenia. You manage them. The biology says: the brain rewires itself constantly — every experience modifies synaptic connections, every day prunes unused circuits and strengthens active ones. The honest answer is between the two, and the specific place where it lands matters for everything that follows.
What the brain actually does every day
The brain is not a fixed circuit. It’s a system that is always changing.
Synaptic plasticity. Every synapse in the brain can strengthen (long-term potentiation, LTP) or weaken (long-term depression, LTD) based on activity patterns. Neurons that fire together wire together — Hebb’s rule, confirmed at the molecular level by the NMDA receptor’s coincidence-detection mechanism (described in post #153). Every time you learn something, synapses change. Every time you forget something, synapses change. This is happening right now, in the brain reading this sentence.
Neurogenesis. New neurons are born in the adult brain — primarily in the hippocampus (the memory hub) and the olfactory bulb. The rate is modest — approximately 700 new neurons per day in the hippocampus — but it’s real and it’s modifiable. Exercise increases hippocampal neurogenesis. Chronic stress decreases it. Antidepressants increase it (this may be part of how SSRIs work — not just serotonin reuptake, but promoting the birth of new neurons).
Dendritic remodeling. Neurons grow and retract dendrites (the branching input structures) in response to experience. A rich sensory environment produces more dendritic branching. Chronic stress produces dendritic retraction in the hippocampus and prefrontal cortex, and dendritic growth in the amygdala (the fear center) — the brain literally reshapes itself to become more anxious and less capable of rational override. This is reversible: when the stress is removed, the dendrites regrow.
Receptor regulation. The density of neurotransmitter receptors on each neuron changes based on how much neurotransmitter it receives. Too much stimulation → the neuron reduces receptor density (downregulation) to protect itself. Too little → it increases receptor density (upregulation) to become more sensitive. This is why tolerance develops to drugs and why withdrawal produces opposite effects — the brain has adapted to the drug’s presence.
Myelination. The insulation (myelin) around neural axons continues forming into the mid-twenties and can be modified by practice throughout life. Musicians have thicker myelin in the tracts connecting auditory and motor cortices. Cab drivers (the London taxi driver studies) have enlarged hippocampi from years of spatial navigation. The brain physically grows the infrastructure for the activities it practices.
This isn’t metaphor. These are measurable physical changes — visible on MRI, quantifiable in tissue samples, demonstrable in animal models where you can count the synapses.
What can be changed
By experience alone
Meditation changes cortical structure. Long-term meditators show increased cortical thickness in the prefrontal cortex and insula — regions involved in attention, interoception, and emotional regulation. Sara Lazar’s lab at Harvard showed these changes in as little as eight weeks of mindfulness practice. The changes are dose-dependent — more practice, more cortical thickness.
Exercise changes neurochemistry directly. Acute exercise increases BDNF (brain-derived neurotrophic factor) — the molecule that promotes synaptic plasticity, neurogenesis, and neuronal survival. Regular exercise increases baseline BDNF levels. Exercise also increases dopamine receptor density (specifically D2 receptors) — meaning the reward system becomes more sensitive, not less. This is the opposite of what drugs of abuse do (which downregulate D2 receptors). Exercise also increases serotonin synthesis, GABA release, and endorphin production.
The neurochemical profile of regular exercise is essentially the opposite of depression: increased BDNF (depression reduces it), increased D2 receptors (depression reduces them), increased serotonin (depression may involve reduced signaling), increased GABA (anxiety involves reduced GABA), increased endorphins (anhedonia involves reduced opioid signaling). Exercise is not a metaphorical antidepressant. It is a literal one, acting through the same mechanisms as pharmacotherapy.
Therapy changes brain function. Cognitive behavioral therapy (CBT) for anxiety produces measurable changes in amygdala reactivity — the amygdala responds less to threat stimuli after successful CBT. These changes are visible on fMRI. Exposure therapy for phobias changes the prefrontal-amygdala circuit — the prefrontal cortex develops stronger inhibitory control over the amygdala’s fear response.
The mechanism: therapy doesn’t add a drug to the brain. It creates experiences that the brain’s plasticity mechanisms use to rewire. The repeated experience of confronting a feared stimulus without catastrophe (exposure therapy) or reappraising a catastrophic thought (CBT) modifies the synaptic connections that encode the fear or the thought pattern.
Sleep consolidates and cleans. Sleep is when the brain’s plasticity mechanisms do their maintenance work. During slow-wave sleep, the hippocampus replays the day’s learning and gradually transfers it to cortical long-term storage (post #137’s consolidation process). During REM sleep, emotional memories are processed and the emotional charge is reduced. The glymphatic system — the brain’s waste-clearance system — is most active during sleep, removing metabolic waste products (including amyloid-β, the protein associated with Alzheimer’s).
Sleep deprivation doesn’t just make you tired. It impairs every plasticity mechanism listed above: reduced LTP, reduced BDNF, reduced neurogenesis, impaired glymphatic clearance, disrupted memory consolidation. The single most effective thing a brain can do for its own biochemistry is sleep.
By pharmacology
SSRIs and serotonin. Selective serotonin reuptake inhibitors block the reabsorption of serotonin, increasing its availability in the synaptic cleft. But the clinical effect takes 2–6 weeks — far longer than the pharmacological effect (which occurs within hours). The current understanding: the acute serotonin increase triggers downstream plasticity changes — increased BDNF, hippocampal neurogenesis, synaptic remodeling — and it’s these plasticity changes, not the serotonin itself, that produce the antidepressant effect. The drug opens a window of plasticity. The brain does the work.
Stimulants and dopamine. Methylphenidate (Ritalin) and amphetamine (Adderall) increase dopamine and norepinephrine in the prefrontal cortex. For ADHD — where prefrontal dopamine signaling is below the threshold needed for executive function — stimulants raise the signal above the threshold. The effect is immediate and dose-dependent. When the drug wears off, the dopamine drops. There’s no lasting change in the architecture — the drug modulates the tuning, not the wiring.
Lithium and everything. Lithium is the oldest and most effective mood stabilizer for bipolar disorder, and its mechanism is still not fully understood after seventy years of use. What’s known: it inhibits GSK-3β (a kinase involved in many signaling pathways including Wnt, mTOR, and circadian rhythms), it promotes BDNF expression, it reduces glutamate excitotoxicity, and it may be neuroprotective (bipolar patients on lithium have larger hippocampal and cortical volumes than those not on lithium). Lithium may be one of the few drugs that actually changes the architecture, not just the tuning — by promoting neuronal survival and BDNF-dependent plasticity over years of use.
Psychedelics and rapid plasticity. Psilocybin, LSD, and DMT produce rapid increases in dendritic spine density (the structural basis of synaptic connections) through activation of TrkB receptors — the same receptors that BDNF activates. A single dose of psilocybin can produce lasting changes in personality (increased openness) and neural connectivity (reduced default mode network rigidity). This is not just a drug effect — it’s the drug opening a window of rapid plasticity that the brain uses to rewire.
The clinical results are striking: psilocybin-assisted therapy for treatment-resistant depression produces remission rates of 50–70% in clinical trials (compared to ~30% for SSRIs in treatment-resistant depression). The mechanism appears to be: the psychedelic produces a brief period of massively enhanced plasticity (the “critical period reopening” hypothesis), during which the therapeutic experience rewires the neural circuits that maintain the depressive state.
What can’t be changed
The architecture set during development
The fundamental wiring plan of the brain — which regions connect to which, the basic circuit architecture, the density and type of neurons in each area — is established during fetal development and early childhood. The critical periods during which this architecture is laid down have time limits.
For autism specifically: the E/I balance that post #153 described as a “dial” is set during a developmental critical period. The genes that influence the GABA excitatory-to-inhibitory switch, the density of PV+ interneurons, the gain of cortical circuits — these are established early. The dial position is not permanently fixed (plasticity continues), but moving it significantly in adulthood is much harder than it would have been during the critical period.
This is why early intervention matters more than later intervention for many neurodevelopmental conditions. The critical period is a window when the architecture is malleable. After the window closes, the architecture is harder (not impossible, but harder) to change.
The genetic range
Genes don’t determine a single outcome — they establish a range of possible outcomes. The technical term is reaction norm: the range of phenotypes a genotype can produce across different environments.
A person with a genetic architecture that positions them at “moderate” on the autism dial cannot, through any known intervention, move themselves to “zero” on the dial. The architecture that determines cortical gain, E/I balance, and sensory processing is built into the brain’s hardware — the number and type of interneurons, the density of glutamate receptors, the mTOR pathway’s set point.
What they can do: optimize their position within the range. Manage sensory environments. Develop compensatory strategies for social communication. Use the enhanced pattern detection in domains where it’s an advantage. The “treatment” is not moving the dial — it’s building a life that works at the dial’s setting.
The same applies to ADHD (the dopamine signaling architecture is set by genetics; stimulants modulate the tuning), bipolar disorder (the mechanisms that produce mood cycling are structural; lithium and mood stabilizers modulate the amplitude), and schizophrenia (the dopamine and glutamate dysregulation is architectural; antipsychotics reduce symptoms without changing the underlying susceptibility).
The cave problem
Victor’s metaphor: “one cannot see outside the cave to notice it is inside a cave.”
This is the deepest limit. The brain that needs to change is the instrument doing the changing. The depressed brain doesn’t experience “low serotonin” — it experiences meaninglessness. The anxious brain doesn’t experience “amygdala hyperactivity” — it experiences danger. The autistic brain doesn’t experience “high cortical gain” — it experiences the world.
The biochemistry shapes the perception. The perception shapes the willingness and ability to change the biochemistry. A depressed person knows, intellectually, that exercise would help. The depression itself — the anhedonia, the fatigue, the executive dysfunction — makes exercising feel impossible. The same biochemistry that needs changing is the biochemistry that prevents the change.
This is not a character flaw. It’s the architecture. The system that needs repair is the system that would have to initiate the repair. A thermostat that’s set wrong can’t fix itself because the setting is what determines what “wrong” looks like to the thermostat.
The external interventions that work — therapy, pharmacology, lifestyle changes initiated by others, structured environments — work partly because they come from outside the cave. The therapist sees the pattern the patient can’t see. The drug changes the biochemistry without requiring the biochemistry’s cooperation. The friend who says “let’s walk” is providing the executive function that the depressed brain has lost.
The honest answer
To what degree can we change the biochemistry of our brain?
The tuning: substantially. Synaptic strength, receptor density, neurotransmitter levels, BDNF expression, cortical thickness, hippocampal volume, amygdala reactivity — all of these are modifiable through experience, pharmacology, or both. The brain changes every day. Intentional change (therapy, exercise, meditation, medication) can direct that change.
The architecture: within limits. The fundamental wiring plan, the E/I balance set during critical periods, the genetic reaction norm — these establish the range. You can optimize within the range. You can’t escape it. The dial position from post #153 can be nudged but not relocated.
The perception of the need to change: the hardest part. The cave problem is real. The brain that needs to change is the brain that evaluates whether change is needed. External interventions — people, drugs, structures — bypass this limit by acting from outside the perception.
Culture says these conditions can’t be cured. Biology says the brain is plastic. Both are right at different scales. The architecture can’t be cured because it’s not broken — it’s a specific way a brain built itself. The tuning can be changed because plasticity never stops. And the gap between “the architecture is permanent” and “the tuning is changeable” is where treatment lives — not curing the condition, but optimizing the brain’s function within the range its architecture allows.
The most honest version: you can’t change what kind of brain you have. You can change how that brain functions within its kind.
Sources
- Lazar, S.W., et al. (2005). Meditation experience is associated with increased cortical thickness. NeuroReport, 16(17), 1893–1897. Cortical changes from meditation.
- Erickson, K.I., et al. (2011). Exercise training increases size of hippocampus and improves memory. PNAS, 108(7), 3017–3022. Exercise and hippocampal volume.
- Santarelli, L., et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301(5634), 805–809. Neurogenesis and antidepressant action.
- Liston, C., et al. (2006). Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. Journal of Neuroscience, 26(30), 7870–7874. Stress-induced dendritic retraction.
- Olson, D.E. (2022). The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects. ACS Pharmacology & Translational Science, 5(3), 140–148. Psychedelic-induced rapid plasticity.
- Carhart-Harris, R.L., et al. (2021). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402–1411. Psilocybin for treatment-resistant depression.
- Xie, L., et al. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342(6156), 373–377. Glymphatic system and sleep.
- Ly, C., et al. (2018). Psychedelics promote structural and functional neural plasticity. Cell Reports, 23(11), 3170–3182. Psychedelic-induced dendritic spine growth.
- Spalding, K.L., et al. (2013). Dynamics of hippocampal neurogenesis in adult humans. Cell, 153(6), 1219–1227. ~700 new neurons/day in the hippocampus.
— Cael